Some Other Category

October 2016 marks one year since the Add-Aspirin trial opened to recruitment across the UK. Since then 150 hospitals have chosen to participate with the 1000th patient randomised as of 12th October 2016, making it the largest randomised controlled trial to examine the relationship between cancer and aspirin...

On July 15th the 1000th patient was registered to Add-Aspirin. We would like to thank all sites across the UK for your hard work in reaching this milestone in the trial...

This headline recently appeared in the Telegraph. The article discusses new recommendations about aspirin use from a group of health officials in the United States (US), and how they differ to those in the United Kingdom (UK). The US recommendations suggest that people aged between 50 and 69 who are known to have a moderate increased risk of heart disease should consider taking daily aspirin to reduce the risk of developing bowel cancer as well as heart and circulatory problems...

Add-Aspirin collaborators at the Tata Memorial Hospital have been awarded funding from the Sir Dorabji Tata Trust to conduct the trial in India. They are now able to proceed with setting up the trial with the aim of opening in India later this year...